This work suggests that maternal hyperglycemia produced by STZ treatment, in combination with early life exposure to an obesogenic diet leads to adult behavioral and metabolic alterations that correlate with increased expression of hypothalamic POMC to promote obesity. Here, POMC is linked to obesity due to melanocortin 4 receptor deficiency.